Compile Data Set for Download or QSAR
Found 12 of ic50 data for polymerid = 1963
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM50423721(CHEMBL595105)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141972(US8927534, 11)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141975(US8927534, 20)copy SMILES
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141976(US8927534, 23)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141978(US8927534, 29)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141994(US8927534, 269)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141973(US8927534, 114 | US8927534, 83)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141981(US8927534, 120)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM50423736(CHEMBL591543)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141986(US8927534, 262)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141990(US8927534, 266)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent
TargetIntegrin alpha-5(Homo sapiens (Human))
Shire Orphan Therapies GmbH

US Patent
LigandPNGBDBM141979(US8927534, 75)copy SMILEScopy InChI
Affinity DataIC50: 100nMpH: 9.6 T: 2°CAssay Description:Fibronectin was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates (Nalge Nu...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2TQ607QUS Patent